£7M to drive commercialisation in cell and gene therapies (CGTs)
MIP Discovery has closed a £7 million GBP (~$9 million USD) Series A financing round, which enables the company to refocus its mission on improving the downstream processing of cell and gene therapies (CGTs), to accelerate widespread adoption of these potentially life-changing medicines. MIP Discovery develops non-biological… Read More